Payer+Provider's Health System Review
Most in-demand states for gastroenterologist placement
'Be courageous and have the gut to invest': 1 oncology leader on collaboration and innovation
May 16, 2023
The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.
Read the full post on Forbes - Healthcare